# DR001 Post-H021 Evidence Pack v1

Status: **FROZEN BEFORE FIRST VALID H021 28-DAY REVISION COHORT**  
Frozen: 2026-10-04  
Portfolio eligibility: disabled  
Live capital: disabled  
Return outcomes opened: no

## Purpose

Join the already-frozen Tier A business dossiers, FQ001 accounting quality,
NV001 own-history valuation, and the future H021 primary EPS-revision comparison
into one deterministic research evidence pack.

The pack does not create a new alpha, ranking, blended score, ADO, or portfolio
decision.

## Frozen pre-H021 input

`research/dr001/dr001-pre-h021-evidence-2026-10-04-v1.json`

Exactly five symbols:

- COFORGE;
- AUROPHARMA;
- MOTHERSON;
- HINDALCO;
- PERSISTENT.

No company can be added after H021 results are observed.

## Frozen H021 inputs

The pack consumes:

1. the H021 primary comparison produced under
   `research/H021_COMPARISON_CONTRACT_V1.md`;
2. the DR001 Tier A H021 research-routing gate produced under
   `research/DR001_H021_TIER_A_GATE_V1.md`.

The H021 comparison remains authoritative for revision eligibility and top-decile
membership.

## Forward-earnings dependency

The pre-H021 evidence stores:

`forward_eps_uplift_vs_fy26_trailing_pct = 100 * (current_trailing_pe / forward_pe - 1)`

Both multiples use the same 2026-10-01 price anchor. Therefore the ratio is the
forward annual EPS uplift implied by the RR001 consensus EPS versus FY26 trailing EPS.

This is context only. It does not alter H021's primary revision signal.

## Output

For every Tier A symbol retain:

- RR001 mid/long state and forward revenue growth;
- FQ001 quality rank/score;
- NV001 valuation rank/score and current-vs-own-history multiple;
- embedded forward EPS uplift versus FY26 trailing EPS;
- H021 EPS revision percentage;
- H021 primary eligibility/reason;
- H021 top-decile membership;
- DR001 gate state and frozen research action.

## Interpretation fields

The pack may add deterministic descriptive flags only:

- `FORWARD_EARNINGS_DEPENDENCY_HIGH` when embedded uplift >= 40%;
- `FORWARD_EARNINGS_DEPENDENCY_MODERATE` when uplift >= 20% and < 40%;
- `FORWARD_EARNINGS_DEPENDENCY_LOW` when uplift < 20%.

These thresholds are frozen before H021 results and are descriptive only. They
do not alter gate state.

The pack may also state whether the H021 revision sign is positive, zero, negative,
or unavailable. No magnitude threshold beyond the frozen H021 rules is introduced.

## Scientific boundary

The evidence pack cannot:

- override an H021 gate state;
- combine FQ001 and NV001 into a new score;
- infer expected return;
- create portfolio eligibility;
- authorize live capital.

Only the existing DR001 H021 gate may advance a name to valuation + red-team review.
